The Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 2 Component(s) Includes a Live Web Event on 01/09/2025 at 2:00 PM (CST)

    The Pharmacy HCT Core Topics Connection Live Session will air on Thursday, January 9, from 2:00 - 3:00 pm CST.

    The Pharmacy HCT Core Topics Connection Live Session will air on Thursday, January 9, at 2:00 - 3:00 pm CST. This live session will focus on two core topics in hematopoietic cell transplantation - HCT Complications and Infectious Diseases in HCT. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and cellular therapy. This webinar will not be recorded and there is no CE offered for attending this session.

    Live Session Faculty:

    HCT Complications

    Grashma Vadakkel, PharmD, BCOP

    Bone Marrow Transplant Clinical Pharmacy Specialist

    Memorial Sloan Kettering Cancer Center

     

    Jade Braun, PharmD, BCOP, BCPS

    Hematology/Oncology Clinical Pharmacist 

    Mayo Clinic Hospital -Rochester

     

    Infectious Diseases in HCT

    Aaron Cumpston, PharmD, BCOP

    Pharmacy Clinical Specialist - Hematological Malignancy, Transplant and Cellular Therapy

    West Virginia University Medicine

     

    Terri Lynn Shigle, PharmD, BCOP

    Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy

    MD Anderson Cancer Center


  • Contains 1 Component(s) Includes a Live Web Event on 12/18/2024 at 2:00 PM (CST)

    The ASTCT Pharmacy SIG Rx-cited: Clinical Conundrums Unplugged - Conducting Pharmacy Research with Busy Clinical Practice session will air on Wednesday, December 18, 2024 from 2-3 p.m. CST.

    Have you ever found yourself stumped by a clinical case and wished you could quickly consult with other pharmacists for immediate guidance? Or perhaps you've been curious about how other pharmacists balance clinical practice and conducting research pharmacists can, but didn’t know where to turn? If you’ve posted questions on the SIG Discussion Board, hoping to spark conversation on unique clinical challenges, or simply wanted more frequent networking opportunities than the annual Tandem Meetings provide, this session is for you!

    Join us for the ASTCT Pharmacy SIG Rx-cited: Clinical Conundrums Unplugged – a dynamic, virtual roundtable designed to generate immediate answers to your clinical questions. This session will focus on how to conduct research while balancing a busy clinical practice and will discuss questions about the use of resources, applications for funding, and more.

    Expect a lively, informal Q&A session moderated by the ASTCT Pharmacy Research Committee. Through chat or open dialogue, you’ll have the opportunity to share insights and learn from your peers in transplantation and cellular therapy.

    This event is open to all pharmacists practicing transplantation and cellular therapy. If you have any questions you'd like addressed during the session, please submit them here: https://forms.office.com/r/mmWmwHea9T

  • Contains 1 Component(s) Includes a Live Web Event on 12/11/2024 at 1:00 PM (CST)

    The ASTCT webinar International Survivorship Guidelines Surveillance Recs on SMN Screening will air on Wednesday, December 11 at 1:00 p.m. CST.

    The webinar will focus on international survivorship guidelines surveillance recs on SMN screening- specifically breast and colorectal cancer and will provide more background and rationale for changes in the recommendations in new guidelines.  

    Speakers:

    Neel S. Bhatt, MBBS, MPH, Fred Hutchinson Cancer Center/ University of Washington 

    Rachel Phelan, MD, MPH, Medical College of Wisconsin/Children’s Wisconsin

    Seth Rotz, MD, Cleveland Clinic Children’s Hospital


  • Contains 1 Component(s)

    The ASTCT Pharmacy SIG September 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST.

    The ASTCT Pharmacy SIG November 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q&A session. In this Journal Club session, Drs. Kasper and Atkins will present on two articles related to: (a) Axatilimab in recurrent or refractory cGvHD and (b) safety and efficacy of maribavir versus valganciclovir inpatients with CMV post-HCT. This session is intended for pharmacists and other members of the health care team who are involved in managing patients undergoing hematopoietic stem cell transplant or cell therapy.

    Presenters & Articles:

    Ryan Kasper, PharmD

    PGY-2 Pharmacy Resident

    University of Pennsylvania

    ArticleAxatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

     

    Payton Atkins, PharmD

    PGY-2 Pharmacy Resident

    University of Kentucky

    Article: Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blinded, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir


    Session Learning Objectives:

    Upon completion of the activity, participants should be able to:

    • Summarize current treatment options for chronic graft-versus-host disease (cGVHD) following allogeneic stem cell transplant
    • Analyze the safety and efficacy of axatilimab at various doses in patients with relapsed or refractory cGVHD
    • Assess the place in therapy of axatilimab based on the data presented in the AGAVE-201 study
    • Discuss current standard of care for the management of CMV in patients post-HCT
    • Analyze the AURORA trial and associated implications for clinical practice
    • Address limitations of the AURORA trial and future research directions for CMV management

    ACCREDITED PROVIDER

    This activity is jointly provided by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT).

    image
    image

          



    image

    In support of improving patient care, this activity has been planned and implemented by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

     

    CREDIT DESIGNATION

    Pharmacists

    image

    This knowledge-based activity qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

    All other healthcare professionals completing this course will be issued a statement of participation.

    The full CE information for this session can be viewed here.

  • Contains 4 Component(s)

    The Pharmacy HCT Core Topics Connection Live Session will air on Tuesday, November 12, at 2 p.m. CT/3 p.m. ET.

    The Pharmacy HCT Core Topics Connection Live Session will air on Tuesday, November 12, at 2 pm CT/3 pm ET. This live session will focus on two core topics in hematopoietic cell transplantation and cellular therapy- Acute GVHD and Chronic GVHD. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and cellular therapy. This webinar will not be recorded. 

    Live Session Faculty:

    Acute Graft vs Host Disease

    C. Brooke Adams, PharmD, BCOP

    Clinical Pharmacy Specialist- Blood and Marrow Transplantation and Cellular Therapy

    Orlando Health Cancer Institute

     

    JoEllen Weilnau, PharmD

    Clinical Pharmacy Coordinator- Hematology/Oncology/Bone Marrow Transplant

    Akron Children's Hospital

     

    Chronic Graft vs Host Disease

    Rebecca Gonzalez, PharmD, BCOP

    Clinical Pharmacist Specialist- Blood and Marrow Transplantation-Cellular Immunotherapy 

    Moffitt Cancer Center

     

    Elizabeth R. Eubanks, PharmD, MPH, BCPS, BCOP

    Clinical Pharmacist Practitioner- Ambulatory Adult Bone Marrow Transplant

    Duke Blood Cancer Center


  • Contains 4 Product(s)

    This educational offering will focus on core topics in hematopoietic cell transplantation (HCT) and cellular therapy. The target audience is PGY2 Oncology Pharmacy Residents, but participation is open to all pharmacists or pharmacy trainees practicing or interested in transplantation and cellular therapy.

    This educational offering will focus on core topics in hematopoietic cell transplantation (HCT) and cellular therapy. The target audience is PGY2 Oncology Pharmacy Residents, but participation is open to all pharmacists or pharmacy trainees practicing or interested in transplantation and cellular therapy.  

    Topics:

    - Graft-versus-Host Disease (GVHD) – Presented by Zahra Mahmoudjafari, PharmD, BCOP, DPLA and Rebecca Gonzalez, PharmD, BCOP
    - Infection Prophylaxis in HCT – Presented by Arpita Shah Gandhi, PharmD, BCOP and Dennis Marjoncu, PharmD, BCOP
    - Chimeric Antigen Receptor (CAR) T-cell Therapies – Presented by Katie S. Gatwood, PharmD, BCOP and May T. Aziz, PharmD, BCOP
    - Conditioning Regimens Used in Hematopoietic Cell Transplantation – Presented by Binni Kunvarjee, PharmD, BCOP, Maggie Nelson, PharmD, BCOP, and Vinita Pai, PharmD, MS  

    Each module includes a recorded presentation, a post-test, a brief evaluation, and a certificate of completion.

  • Contains 1 Component(s)

    The ASTCT Pharmacy SIG Career Search Panel will take place on Wednesday, October 23th at 2 p.m. CDT/ 3 p.m. EDT.

    Please join us for the ASTCT Pharmacy SIG Career Search Panel on Wednesday, October 23th at 2 p.m. CDT/ 3 p.m. EDT.  This live session will feature a panel of pharmacists in traditional and non-traditional oncology pharmacy roles discussing their respective career paths. The goal of this session is to assist new and current pharmacy practitioners with navigating their career journeys by allowing them to engage with oncology pharmacists working in a variety of practice settings. This event is open to all healthcare professionals who are members and non-members of ASTCT. We hope to see you on October 23!  

    Panelists: 

    • Amber Clemmons PharmD, BCOP, FHOPA - Clinical Professor University of Georgia College of Pharmacy, BMT Clinical Pharmacist at Wellstar-MCG Health, PGY2 Oncology Residency Director UGA/Wellstar-MCG Health   
    • Julianna Roddy-McLean, PharmD, BCOP - Hematology Regional Medical Scientific Director at Merck      
    • LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA - Atrium Health Wake Forest Baptist PGY2 Oncology Residency Program Director, Oncology Clinical Manager at Atrium Health Wake Forest Baptist, Pharmacy Clinical Specialist in Stem Cell Transplant and Cellular Therapy, HOPA President  
    • David DeRemer, PharmD, BCOP, FCCP, FHOPA - Clinical Professor at the University of Florida College of Pharmacy and the Assistant Director of Experimental Therapeutics Group at the University of Florida Health Cancer Center  
    • Kelly Gaertner Brandt, PharmD, BCOP, BCPS - Oncology Clinical Pharmacy Specialist Allegheny Health Network Cancer Institute
  • Contains 2 Component(s)

    The webinar, 'Immune Effector Cell Therapies: Best Practices for Financial and Administrative Operations Success,' will take place on Thursday, October 10th from 11-12 p.m. CDT.

    The ASTCT Payor Relations Committee will host the webinar, 'Immune Effector Cell Therapies: Best Practices for Financial and Administrative Operations Success,' on October 10th from 11-12 p.m. CDT. This webinar will provide guidance on the unique patient authorization workflows and administrative oversight to implement and operate a successful immune effector cell therapy program. Faculty from the Payor Relations Committee will review best practices for establishing interdisciplinary workflows, focusing on institutional staff roles and participation, common pitfalls steps required to ensure expected reimbursement. This is a great chance for new centers to learn how experienced centers have evolved their approach to administrative workflows for these complex therapies. This webinar is free and open to ASTCT members and non-members.


    Faculty:

    Amy Emmert, MScPH; Executive Director for Cellular Therapy External Affairs at Dana Farber Cancer Institute

    Cynthia Devroy, Manager, Oncology Business Operations, Northside Hospital

    Catherine Cardona, Program Analyst, Blood and Marrow Transplant and Cellular Therapies Program, The University of Kansas Cancer Center

    Gary Goldstein, Senior Manager, BMT and Cellular Therapy Program, Stanford Health Care




  • Contains 1 Component(s) Recorded On: 09/18/2024

    The Future Directions Palliative Care webinar aired on Wednesday, September 18th at 12:00 p.m. CT.

    This third webinar of 2024 presented by the Palliative Care SIG will focus on lessons learned in the field and important research questions that must be answered in the future to further advance the science of palliative and supportive care to meet the needs of patients throughout the continuum of the illness.

    Speakers:

    Areej El-Jawahri, MD. Massachusetts General Hospital

    Susan McInnes, MD, Cleveland Clinic

    Effie Petersdorf, MD, University of Washington

    Moderator:

    Christina Ullrich, MD, MPH, Dana-Farber Cancer Institute

  • Contains 2 Product(s)

    The 2024 CAR T Webinar Series debuted in June 2024, highlighting the Best of CAR T at the 2024 Tandem Meetings and new developments in CAR T Treatments. Recordings and slides from the live webinars have been posted here for your easy viewing.

    The 2024 CAR T Webinar Series debuted in June 2024, highlighting the Best of CAR T at the 2024 Tandem Meetings and new developments in CAR T Treatments. Recordings and slides from the live webinars have been posted here for your easy viewing.


    Thank you to Johnson & Johnson and Legend Biotech for their generous support of this webinar series.